P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY
P1225:淋巴瘤患者接受大剂量化疗(HDT)联合自体干细胞移植(ASCT)后继发性原发性恶性肿瘤(SPM):一项丹麦全国性队列研究
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-022-02470-7
Cao, Xiaocheng; Liu, Lihua; Yuan, Qing; Li, Xiang; Cui, Yinghong; Ren, Kaiqun; Zou, Chang; Chen, A; Xu, Chang; Qiu, Yebei; Quan, Meifang; Zhang, Jiansong; Cao, Jianguo; Chen, Xiangding; Rask Kragh Jørgensen, R; Eloranta, S; Tang Severinsen, M; Kiesbye Øvlisen, A; Bjøro Smeland, K; Kiserud, C; Haaber Christensen, J; Hutchings, M; Bo-Dahl Sørensen, R; Kamper, P; Glimelius, I; Smedby, K E; Bergström, F; El-Galaly, T C; Hjort Jakobsen, L; Trab, T; Baech, J; Hjort Jakobsen, L; Husby, S; Tang Severinsen, M; Eloranta, S; Gørløv, J S; Jørgensen, J M; Gudbrandsdottir, S; Stauffer Larsen, T; Brown, P; Smedby, K E; Christoffer El-Galaly, T
肿瘤
肿瘤免疫
细胞生物学
淋巴瘤
ASC
干细胞
发育与干细胞